ALL patient samples used in the study
| Sample no. . | Diagnosis . | Blast count at diagnosis, % . | Diagnostic material . | Outcome . |
|---|---|---|---|---|
| 1 | AML with t(1;7) and t(9;11) | 88 | Peripheral blood | Relapse (10 mo) |
| 2 | pre–B-ALL “common ALL”; EGIL II | 96 | BM | Remission (2 mo) |
| Sample no. . | Diagnosis . | Blast count at diagnosis, % . | Diagnostic material . | Outcome . |
|---|---|---|---|---|
| 1 | AML with t(1;7) and t(9;11) | 88 | Peripheral blood | Relapse (10 mo) |
| 2 | pre–B-ALL “common ALL”; EGIL II | 96 | BM | Remission (2 mo) |